NeuroSense Therapeutics Overview

NeuroSense Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NRSN.

Quarterly EBIT

-$2.35M

↑ 22.57% YoY

As of Jun 30, 2025

Annual EBIT (TTM)

-$8.57M

↑ 29.8% YoY

Trailing 12 months ending Jun 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin